Related Experiment Videos
[Treatment of onychomycoses]
1Kenézy Gyula Kórház-Rendelóintézet, Mikológiai Laboratórium, Debrecen.
Abstract:
The author reviews the prevalence of onychomycoses and the factors influencing it. Among the precipitating factors, age and various predisposing diseases play a role in the development of the disease play a role in the development of the disease. The problem affects the toenails more frequently than the fingernails. Distal subungual onychomycosis caused by dermatophytons is most often seen among the various types of the disease. Yeasts and moulds mainly act as contaminants. New diagnostic methods facilitate more precise diagnosis but they cannot replace basic mycological investigations. Orally administered antifungal agents have appeared in the foreground of treatment. Among them fluconazole, itraconazole and terbinafin derivatives can safely be applied in combination with certain cauterants. Each of the three agents are effective in approximately 70-80% of cases, especially when applied on fingernails. Combined therapy, such as the application of oral antimycotics and antifungal lacquerers or oral treatment accompanied by the surgical, laser or chemical removal of the affected nail regions, can improve the results. Surviving fungal residues in the substance of the nail may restart the disease. Relapse may also be attributed to neglecting the desinfection of shoes. When choosing the drugs, drug interaction should also be considered. The above three oral antimycotics have few (1-20%) side effects, gastrointestinal ones being the most common among them. A transitory elevation in hepatic enzyme levels may sometimes occur but the changes go back to normal after treatment is over.
Insights
Onychomycosis, a fungal nail infection, is common and influenced by age and disease. Effective oral antifungal treatments like fluconazole, itraconazole, and terbinafine offer high success rates, especially for fingernails.
Area of Science:
- Medical Mycology
- Dermatology
- Pharmacology
Context:
- Onychomycosis is a prevalent fungal nail infection.
- Factors influencing onychomycosis include age and predisposing diseases.
- Toenails are more frequently affected than fingernails.
Purpose:
- To review the prevalence, influencing factors, diagnosis, and treatment of onychomycosis.
- To discuss the efficacy of oral antifungal agents and combination therapies.
- To highlight considerations for treatment, including drug interactions and relapse prevention.
Summary:
- Distal subungual onychomycosis, often caused by dermatophytes, is the most common type.
- Newer diagnostic methods complement traditional mycological investigations.
- Oral antifungals (fluconazole, itraconazole, terbinafine) are primary treatments, achieving 70-80% efficacy, particularly for fingernails.
- Combination therapies (oral antifungals with topical treatments or procedures) can enhance outcomes.
- Preventing relapse involves addressing fungal residues and disinfecting footwear.
Impact:
- Improved understanding of onychomycosis contributes to better patient management.
- Evidence-based treatment strategies can lead to higher cure rates and reduced recurrence.
- Awareness of potential drug interactions and side effects ensures safer therapeutic choices.